Hepatitis C; Chronic Clinical Trials

A listing of Hepatitis C; Chronic medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 15 clinical trials
Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis C

The safety, tolerability and antiviral activity of Antaitavir Hasophate in Combination With Yiqibuvir in treatment-naive and treatment-experienced patients with chronic hepatitis C virus (HCV

  • 04 Jun, 2022
  • 27 locations
Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy (STORC)

This is a multicenter, single arm study of Sofosbuvir/Velpatasvir (SOF/VEL) for treatment of chronic hepatitis C infection during pregnancy. Treatment will be initiated during the second or

  • 06 May, 2022
  • 1 location
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

complications of liver disease after cure of hepatitis C infection. Eligibility Adults 18 years and older infected with chronic hepatitis C virus who were never treated or

antiviral drugs
liver cancer
glycosylated hemoglobin
chronic hepatitis
  • 27 Jul, 2022
  • 1 location
Risk Stratification of Hepatocarcinogenesis Using a Deep Learning Based Clinical, Biological and Ultrasound Model in High-risk Patients (STARHE)

limitations: lack of personalisation, low compliance, relatively poor performance of the ultrasound. Risk stratification models have been developed for chronic hepatitis C, alcoholic cirrhosis and non

  • 27 Apr, 2022
  • 4 locations
Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia

Background Severe aplastic anemia is a rare and serious blood disorder. It happens when the immune system starts to attack the bone marrow cells. This causes the bone marrow to stop making red blood cells, platelets, and white blood cells. Standard treatment for this disease is horse-ATG and cyclosporine, which …

blood test
reticulocyte count
neutrophil count
  • 21 Apr, 2022
  • 1 location
Nation-wide Hepatitis C Virus (HCV) Registry in Taiwan

To determine the treatment efficacy, safety and long-term outcomes of chronic hepatitis C patients receiving directly acting antivirals in Taiwan

antiviral drugs
chronic hepatitis
  • 26 Apr, 2022
  • 1 location
Long Term Follow up of Chronic HCV Patients Receiving DAAS

Follow up of Chronic hepatitis C Patients with moderate to severe fibrosis and cirrhosis treated with Direct Acting Antivirals after Sustained Virological Response for 4-5 years to detect

  • 07 Jul, 2022
  • 1 location
Surveillance for Antiviral Resistant Variants in Chronic Hepatitis C Patients (SEARCH-C)

This is a multi-centre prospective longitudinal cohort study with the aim of collecting and storing clinical data, patient blood, DNA and PBMCs to examine outcomes related to drug resistance, drug monitoring and host genetics in the era of directly acting antiviral drugs for hepatitis C therapy.

  • 21 Apr, 2022
  • 2 locations
COVID-19 Vaccine and Development of Immune Thrombocytopenic Purpura

Detect development of immune thrombocytopenic purpura (ITP) after different types of (COVID-19) vaccination

Accepts healthy volunteers
  • 26 Jul, 2022
  • 1 location
Evaluating the Chain of Addiction Care (CAC) (HepC:CAC)

The investigators want to evaluate the feasibility of a decentralised hepatitis C care pathway (the Chain of Addiction Care (CAC) pathway) in several addiction care centres in the east of the Netherlands. Secondary objective: to measure the impact of hepatitis C clearance on MET (+metabolite) and BUP (+metabolite) trough levels …

  • 17 Jun, 2022
  • 1 location